| 11/22/2019 | CVLM | Fluidigm buys back $50.2 million 2.75% convertibles for $51.8 million
|
| 11/22/2019 | CV | Fluidigm greenshoe increases 5.25% convertibles to $55 million
|
| 11/21/2019 | CV | Market Commentary: Overnight Liberty Media/Sirius exchangeables model cheap; Tilray adds with higher shares
|
| 11/20/2019 | CV | Market Commentary: Chefs’ Warehouse edges up; Fluidigm prices $50 million deal; Pinduoduo tanks outright
|
| 11/20/2019 | CV | New Issue: Fluidigm prices upsized $50 million five-year convertibles to yield 5.25%, up 25%
|
| 11/20/2019 | CV | Market Commentary: Morning Commentary: Chefs’ Warehouse edges up; Fluidigm on tap; Medicines off highs
|
| 11/20/2019 | CV | Fluidigm to sell $45 million five-year convertibles at 5%, up 25%
|
| 3/13/2018 | BWCV | Fluidigm committed to cutting cash burn, generates cash during 2017
|
| 3/13/2018 | CVLM | Fluidigm to exchange $25 million more 2.75% convertibles due 2034
|
| 3/2/2018 | CVLM | Fluidigm to exchange $125 million 2.75% convertibles due 2034, up 15%
|
| 10/20/2016 | CV | Market Commentary: Convertibles see positive tone; DISH bonds expand on swap; Citrix bonds add; Peabody gains
|
| 10/13/2016 | CV | Market Commentary: Teva convertibles rise on swap; Fluidigm, Illumina pressured; Tesla bounces; DISH heavy
|
| 10/13/2016 | CV | Market Commentary: Morning Commentary: Fluidigm sinks on preliminary results; Macquarie Infrastructure debt in play
|
| 1/20/2016 | CV | Market Commentary: Convertibles ‘for sale’ as equities fall; Stone Energy drops to 55, Fluidigm to below 50
|
| 1/20/2016 | CV | Market Commentary: Morning Commentary: Markets sell off as crude oil drags lower; Stone Energy down to 60
|
| 11/3/2015 | CV | Market Commentary: AMAG Pharmaceuticals tumbles outright on earnings miss; Priceline edges up; Ctrip in line
|
| 8/7/2015 | CV | Market Commentary: Fluidigm ‘comes in’ on the back of disappointing earnings; Iconix drops; Post expands slightly
|
| 8/7/2015 | CV | Market Commentary: Morning Commentary: Fluidigm ‘comes in’ on the back of disappointing earnings; Post shares pop
|
| 5/8/2015 | CV | Market Commentary: Fluidigm down outright, expands on swap after earnings; Nvidia in line on swap; PHH active
|
| 6/5/2014 | CV | Market Commentary: SunEdison expands 2-3 points on hedge; Illumina sells upsized $1 billion deal; some selling
|
| 5/6/2014 | CV | Market Commentary: Midday Commentary: Fluidigm mostly in line after earnings; Prospect Capital paper active
|
| 5/6/2014 | CV | Market Commentary: Fluidigm drops outright, in line on hedge after earnings; planned American Tower deal eyed
|
| 5/5/2014 | CV | Market Commentary: Convertibles mostly quiet; BroadSoft drops in line; Iridium, American Tower deals on tap
|
| 5/2/2014 | CV | Market Commentary: Midday Commentary: Hologic active again; Fluidigm looks stronger; BioMarin shares down
|
| 5/2/2014 | CV | Market Commentary: BioMarin lower outright on earnings; Fluidigm stronger ahead of earnings; Hologic active
|
| 4/7/2014 | CV | Market Commentary: Convertibles in line to slightly higher on hedge; Tesla, Priceline, Fluidigm in trade
|
| 2/5/2014 | CV | Market Commentary: Cepheid convertibles add on debut; Fluidigm extends gains; secondary sees slow action
|
| 2/4/2014 | CV | Fluidigm greenshoe exercise increases convertibles to $201.25 million
|
| 1/30/2014 | CV | Market Commentary: Midday Commentary: Fluidigm zooms higher on debut; Lam Research adds after earnings; KB Home trades
|
| 1/30/2014 | CV | New Issue: Fluidigm prices $175 million 20-year convertibles at 2.75%, up 40%
|
| 1/30/2014 | CV | Market Commentary: New Fluidigm zooms higher in active trade; homebuilders mostly in line; Lam Research adds
|
| 1/29/2014 | CV | Market Commentary: Midday Commentary: Fluidigm launches $175 million convertible; WellPoint lower after earnings
|
| 1/29/2014 | CV | Fluidigm plans to sell $175 million 20-year convertibles to yield 2.75%-3.25%, up 30%-35%
|
| 1/29/2014 | CV | Price talk for Fluidigm's $175 million 20-year convertibles tightened to 2.75%, up 35%-40%
|
| 1/29/2014 | CV | Market Commentary: Fluidigm talk tightened; Medivation jumps on positive trial data; Illumina trades in line
|
| 4/4/2012 | CVHYPF | Fluidigm files $100 million shelf covering stock, debt and preferreds
|
